Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Id proteins: Novel targets of activin action, which regulate epidermal homeostasis

Abstract

Activin is a member of the transforming growth factor β (TGF-β) family, which plays a crucial role in skin morphogenesis and wound healing. To gain insight into the underlying mechanisms of action, we searched for activin-regulated genes in cultured keratinocytes. One of the identified target genes encodes Id1, a negative regulator of helix–loop–helix transcription factors. We show that Id1, Id2, and Id3 are strongly downregulated by activin in keratinocytes in vitro and in vivo. To determine the role of Id1 in keratinocyte biology, we generated stable HaCaT keratinocyte cell lines overexpressing this protein. Our results revealed that enhanced levels of Id1 do not affect proliferation of keratinocytes in monoculture under exponential culture conditions or in response to activin or TGF-β1. However, in three-dimensional organotypic cultures, Id1-overexpressing HaCaT cells formed a hyperthickened and disorganized epithelium that was characterized by enhanced keratinocyte proliferation, abnormal differentiation, and an increased rate of apoptosis. These results identify an important function of Id1 in the regulation of epidermal homeostasis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Bamberger C, Schärer A, Antsiferova M, Tychsen B, Pankow S, Müller M et al. (2005). Am J Pathol 167: 733–747.

  • Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H . (1990). Cell 61: 49–59.

  • Bjorntorp E, Parsa R, Thornemo M, Wennberg AM, Lindahl A . (2003). Acta Derm Venerol 83: 403–409.

  • Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE . (1988). J Cell Biol 106: 761–771.

  • Chambers RC, Leoni P, Kaminski N, Laurent GJ, Heller RA . (2003). Am J Pathol 162: 533–546.

  • Chaturvedi V, Bonish B, Bacon P, Qin JZ, Denning MF, Foreman K et al. (2003). Exp Dermatol 12: 255–260.

  • Chomczynski P, Sacchi N . (1987). Anal Biochem 162: 156–159.

  • Cruise BA, Xu P, Hall AK . (2004). Dev Biol 271: 1–10.

  • Deed RW, Hirose T, Mitchell EL, Santibanez-Koref MF, Norton JD . (1994). Gene 151: 309–314.

  • Frank S, Madlener M, Werner S . (1996). J Biol Chem 271: 10188–10193.

  • Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H et al. (1994). J Biol Chem 269: 2139–2145.

  • Hübner G, Hu Q, Smola H, Werner S . (1996). Dev Biol 173: 490–498.

  • Kang Y, Chen CR, Massague J . (2003). Mol Cell 11: 915–926.

  • Korchynskyi O, ten Dijke P . (2002). J Biol Chem 277: 4883–4891.

  • Kowanetz M, Valcourt U, Bergstrom R, Heldin CH, Moustakas A . (2004). Mol Cell Biol 24: 4241–4254.

  • Kretschmer A, Moepert K, Dames S, Sternberger M, Kaufmann J, Klippel A . (2003). Oncogene 22: 6748–6763.

  • Kurisaki K, Kurisaki A, Valcourt U, Terentiev AA, Pardali K, Ten Dijke P et al. (2003). Mol Cell Biol 23: 4494–4510.

  • Langlands K, Down GA, Kealey T . (2000). Cancer Res 60: 5929–5933.

  • Lasorella A, Uo T, Iavarone A . (2001). Oncogene 20: 8326–8333.

  • Lin CQ, Parrinello S, Campisi J, Desprez PY . (1999). Endocr Relat Cancer 6: 49–50.

  • Ling MT, Wang X, Tsao SW, Wong YC . (2002). Biochim Biophys Acta 1570: 145–152.

  • Maas-Szabowski N, Starker A, Fusenig NE . (2003). J Cell Sci 116: 2937–2948.

  • Martin P . (1997). Science 276: 75–81.

  • Massague J . (1990). Annu Rev Cell Biol 6: 597–641.

  • Mathews LS, Vale WW . (1993). Receptor 3: 173–181.

  • Munz B, Smola H, Engelhardt F, Bleuel K, Brauchle M, Lein I et al. (1999). EMBO J 18: 5205–5215.

  • Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H . (1990). Science 247: 836–838.

  • Norton JD, Deed RW, Craggs G, Sablitzky F . (1998). Trends Cell Biol 8: 58–65.

  • Ohga E, Matsuse T, Teramoto S, Katayama H, Nagase T, Fukuchi Y et al. (1996). Biochem Biophys Res Commun 228: 391–396.

  • Ruzinova MB, Benezra R . (2003). Trends Cell Biol 13: 410–418.

  • Ryle CM, Breitkreutz D, Stark HJ, Leigh IM, Steinert PM, Roop D et al. (1989). Differentiation 40: 42–54.

  • Schaefer BM, Koch J, Wirzbach A, Kramer MD . (2001). Exp Cell Res 266: 250–259.

  • Schoop VM, Mirancea N, Fusenig NE . (1999). J Invest Dermatol 112: 343–353.

  • Seishima M, Nojiri M, Esaki C, Yoneda K, Eto Y, Kitajima Y . (1999). J Invest Dermatol 112: 432–436.

  • Shimizu A, Kato M, Nakao A, Imamura T, ten Dijke P, Heldin CH et al. (1998). Genes Cells 3: 125–134.

  • Shipley GD, Pittelkow MR, Wille Jr JJ, Scott RE, Moses HL . (1986). Cancer Res 46: 2068–2071.

  • Siegel PM, Shu W, Massague J . (2003). J Biol Chem 278: 35444–35450.

  • Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM . (2003). Cancer Cell 3: 525–530.

  • Singer AJ, Clark RA . (1999). N Engl J Med 341: 738–746.

  • Smola H, Stark HJ, Thiekotter G, Mirancea N, Krieg T, Fusenig NE . (1998). Exp Cell Res 239: 399–410.

  • Stark HJ, Baur M, Breitkreutz D, Mirancea N, Fusenig NE . (1999). J Invest Dermatol 112: 681–691.

  • Tsuchida K, Nakatani M, Yamakawa N, Hashimoto O, Hasegawa Y, Sugino H . (2004). Mol Cell Endocrinol 220: 59–65.

  • Wankell M, Kaesler S, Zhang YQ, Florence C, Werner S, Duan R . (2001a). J Endocrinol 171: 385–395.

  • Wankell M, Munz B, Hubner G, Hans W, Wolf E, Goppelt A et al. (2001b). EMBO J 20: 5361–5372.

  • Watt FM . (2002). EMBO J 21: 3919–3926.

  • Werner S, Beer HD, Mauch C, Luscher B, Werner S . (2001). Oncogene 20: 7494–7504.

  • Werner S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH et al. (1994). Science 266: 819–822.

  • Werner S, Weinberg W, Liao X, Peters KG, Blessing M, Yuspa SH et al. (1993). EMBO J 12: 2635–2643.

  • Yamashita S, Maeshima A, Kojima I, Nojima Y . (2004). J Am Soc Nephrol 15: 91–101.

  • Zhang L, Deng M, Parthasarathy R, Wang L, Mongan M, Molkentin JD et al. (2005). Mol Cell Biol 25: 60–65.

Download references

Acknowledgements

We thank Christiane Born-Berclaz and Iris Nord for excellent technical assistance and Dr Takako Sasaki, Max-Planck-Institute of Biochemistry, Martinsried, Germany, for kindly providing the laminin-5 antibody. This work was supported by a grant from the Swiss National Science Foundation (31-61358.00) to SW and a grant from the EC/Swiss Ministry for Education and Research (LSHG-CT-2003-503447, WOUND) to SW and PB.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Werner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rotzer, D., Krampert, M., Sulyok, S. et al. Id proteins: Novel targets of activin action, which regulate epidermal homeostasis. Oncogene 25, 2070–2081 (2006). https://doi.org/10.1038/sj.onc.1209230

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209230

Keywords

This article is cited by

Search

Quick links